Login / Signup

The French multicentre elevated bone mass study: prevalence and causes.

Julien PaccouR-M JavierI Henry-DesaillyC TernynckA NottezI Legroux-GérotF RobinP FardelloneE LespessaillesC RouxP GuggenbuhlS KoltaB Cortet
Published in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2021)
The prevalence of EBM was approximately 1 in 100. These findings suggest that degenerative disease of the spine is the main cause of EBM, but that acquired or hereditary diseases are also causal factors.
Keyphrases
  • risk factors
  • clinical trial
  • study protocol
  • randomized controlled trial
  • cross sectional
  • double blind
  • postmenopausal women